financetom
Business
financetom
/
Business
/
CME Group plans to launch Solana futures on March 17
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CME Group plans to launch Solana futures on March 17
Feb 28, 2025 7:17 AM

Feb 28 (Reuters) - CME Group ( CME ) said on Friday that

it plans to roll out futures contracts on cryptocurrency Solana

on March 17, pending regulatory review.

The exchange said it expects to debut two contracts, one for

500 Solana coins and a "micro-sized" contract for 25 Solana.

If the products get the regulatory stamp of approval, the

launch would clear the way for approvals of exchange-traded

funds tied to Solana. Several asset management firms already

have filed for regulatory approval to launch such products.

(Reporting by Suzanne McGee in New York)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Revive Therapeutics Updates on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Revive Therapeutics Updates on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Aug 28, 2024
07:27 AM EDT, 08/28/2024 (MT Newswires) -- Revive Therapeutics ( RVVTF ) on Wednesday said a research study evaluating Bucillamine as a potential treatment for nerve agent exposure, is expected to be completed in October. The study is being conducted in partnership with an agency of the Canadian Department of National Defence. The results from the study, if promising, will...
GSK Says Nucala Approved in Japan to Treat Chronic Rhinosinusitis With Nasal Polyps
GSK Says Nucala Approved in Japan to Treat Chronic Rhinosinusitis With Nasal Polyps
Aug 28, 2024
07:25 AM EDT, 08/28/2024 (MT Newswires) -- GSK (GSK) said Wednesday that Japan's Ministry of Health, Labor and Welfare had approved Nucala, or mepolizumab, to treat chronic rhinosinusitis with nasal polyps in adults. The approval is based on phase 3 trial data and supported by the results of a global study, GSK said. Mepolizumab is also approved in Japan for...
EV maker Polestar taps industry veteran as CEO to shake-up faltering business
EV maker Polestar taps industry veteran as CEO to shake-up faltering business
Aug 28, 2024
STOCKHOLM, Aug 28 (Reuters) - Polestar will replace long-serving CEO Thomas Ingenlath with a former boss of Opel and EV startups as the company fights to shake up its business after years of delayed model launches, missed delivery targets and further separation from Volvo Cars. Its new CEO, Michael Lohscheller has previously served as CEO of Stellantis ( STLA )-owned...
--Deere Keeps Quarterly Dividend at $1.47 a Share; Payable Nov. 8 to Shareholders on Sept. 30
--Deere Keeps Quarterly Dividend at $1.47 a Share; Payable Nov. 8 to Shareholders on Sept. 30
Aug 28, 2024
11:51 AM EDT, 08/28/2024 (MT Newswires) -- Price: 378.13, Change: +2.14, Percent Change: +0.57 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved